1KKQ - Header Asymmetric Unit

HEADER TRANSCRIPTION 10-DEC-01 1KKQ

TITLE CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN TITLE 2 COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: PPAR-ALPHA LBD; COMPND 5 SYNONYM: PPAR-ALPHA LIGAND-BINDING DOMAIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NUCLEAR RECEPTOR CO-REPRESSOR 2; COMPND 9 CHAIN: E, F, G, H; COMPND 10 FRAGMENT: SMRT RECEPTOR INTERACTING MOTIF; COMPND 11 SYNONYM: NUCLEAR COREPRESSOR SMRT C-TERMINAL RECEPTOR INTERACTING COMPND 12 MOTIF; COMPND 13 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HUMAN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_ORGAN: LIVER; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: T7 PROMOTER FROM PRSETA; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PRSETA; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: SMRT RECEPTOR INTERACTING MOTIF: THIS SEQUENCE OCCURS SOURCE 15 NATURALLY IN HUMANS.

KEYWDS NUCLEAR COREPRESSOR NUCLEAR HORMONE RECEPTORS ANTAGONIST, KEYWDS 2 TRANSCRIPTION

EXPDTA X-RAY DIFFRACTION

AUTHOR H.E.XU,T.B.STANLEY,V.G.MONTANA,M.H.LAMBERT,B.G.SHEARER,J.E.COBB, AUTHOR 2 D.D.MCKEE,C.M.GALARDI,R.T.NOLTE,D.J.PARKS

REVDAT 5 01-FEB-17 1KKQ 1 AUTHOR REVDAT 4 18-SEP-13 1KKQ 1 REMARK VERSN REVDAT 3 24-FEB-09 1KKQ 1 VERSN REVDAT 2 27-FEB-02 1KKQ 1 JRNL REVDAT 1 20-FEB-02 1KKQ 0

JRNL AUTH H.E.XU,T.B.STANLEY,V.G.MONTANA,M.H.LAMBERT,B.G.SHEARER, JRNL AUTH 2 J.E.COBB,D.D.MCKEE,C.M.GALARDI,K.D.PLUNKET,R.T.NOLTE, JRNL AUTH 3 D.J.PARKS,J.T.MOORE,S.A.KLIEWER,T.M.WILLSON,J.B.STIMMEL JRNL TITL STRUCTURAL BASIS FOR ANTAGONIST-MEDIATED RECRUITMENT OF JRNL TITL 2 NUCLEAR CO-REPRESSORS BY PPARALPHA. JRNL REF NATURE V. 415 813 2002 JRNL REFN ISSN 0028-0836 JRNL PMID 11845213

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.E.XU,M.H.LAMBERT,V.G.MONTANA,T.M.WILLSON REMARK 1 TITL STRUCTURAL DETERMINANTS OF LIGAND BINDING SELECTIVITY REMARK 1 TITL 2 BETWEEN THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 98 13919 2001 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.241410198

REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 4983740.500 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 29242 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.290 REMARK 3 R VALUE (WORKING SET) : 0.258 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2335 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 29737 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4271 REMARK 3 BIN R VALUE (WORKING SET) : 0.3860 REMARK 3 BIN FREE R VALUE : 0.4210 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 367 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9096 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 180 REMARK 3 SOLVENT ATOMS : 330 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 31.36000 REMARK 3 B22 (A**2) : -10.76000 REMARK 3 B33 (A**2) : -20.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM SIGMAA (A) : 0.55 REMARK 3 LOW RESOLUTION CUTOFF (A) : 50.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.53 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.60 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.500 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.050 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.580 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.890 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.650 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.850 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LOCALPARM.XPL REMARK 3 PARAMETER FILE 4 : BSXPI3_BOND.XPL REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : INFILE_1 REMARK 3 TOPOLOGY FILE 2 : INFILE_2 REMARK 3 TOPOLOGY FILE 3 : INFILE_3 REMARK 3 TOPOLOGY FILE 4 : INFILE_4 REMARK 3 TOPOLOGY FILE 5 : INFILE_5 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1KKQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-DEC-01. REMARK 100 THE RCSB ID CODE IS RCSB015057.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MONOCHROMATOR CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29380 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.02300 REMARK 200 R SYM (I) : 0.06600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.15800 REMARK 200 R SYM FOR SHELL (I) : 0.06200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1K7L REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG35K, PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 51.70450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.97700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.38650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.97700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 51.70450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 56.38650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 200 OG1 CG2 REMARK 470 THR B 200 OG1 CG2 REMARK 470 THR C 200 OG1 CG2 REMARK 470 THR D 200 OG1 CG2 REMARK 470 ASN E 682 CG OD1 ND2 REMARK 470 LYS E 696 CG CD CE NZ REMARK 470 GLN E 699 CG CD OE1 NE2 REMARK 470 ASN F 682 CG OD1 ND2 REMARK 470 GLN F 699 CG CD OE1 NE2 REMARK 470 ASN G 682 CG OD1 ND2 REMARK 470 LYS G 696 CG CD CE NZ REMARK 470 GLN G 699 CG CD OE1 NE2 REMARK 470 ASN H 682 CG OD1 ND2 REMARK 470 LYS H 696 CG CD CE NZ REMARK 470 GLN H 699 CG CD OE1 NE2

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG D 348 CG LYS D 349 1.74 REMARK 500 O GLY C 231 N ALA C 233 1.90 REMARK 500 O LEU G 685 CD1 ILE G 688 1.92 REMARK 500 O GLU B 451 OD1 ASP B 453 1.92 REMARK 500 O SER C 230 N LYS C 232 2.07 REMARK 500 O ASN A 219 NZ LYS A 224 2.10 REMARK 500 O LYS A 448 OG SER A 452 2.19 REMARK 500 O PHE D 343 OG SER D 346 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU B 267 N - CA - C ANGL. DEV. = -19.8 DEGREES REMARK 500 ASN C 236 N - CA - C ANGL. DEV. = -17.2 DEGREES REMARK 500 LYS C 266 N - CA - C ANGL. DEV. = -17.4 DEGREES REMARK 500 GLU C 451 N - CA - C ANGL. DEV. = -21.0 DEGREES REMARK 500 LEU C 456 N - CA - C ANGL. DEV. = -16.7 DEGREES REMARK 500 GLN C 461 N - CA - C ANGL. DEV. = -20.3 DEGREES REMARK 500 ASN D 236 N - CA - C ANGL. DEV. = -19.3 DEGREES REMARK 500 GLU D 462 N - CA - C ANGL. DEV. = 17.4 DEGREES REMARK 500 GLY F 695 N - CA - C ANGL. DEV. = 19.0 DEGREES REMARK 500 GLY G 695 N - CA - C ANGL. DEV. = 17.1 DEGREES REMARK 500 LYS G 696 N - CA - C ANGL. DEV. = 16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 201 -58.78 -169.28 REMARK 500 ARG A 209 -19.25 -46.94 REMARK 500 LEU A 215 30.97 -75.66 REMARK 500 LYS A 216 -7.71 -154.32 REMARK 500 LEU A 229 -83.01 -55.87 REMARK 500 LYS A 232 -167.88 -162.01 REMARK 500 ALA A 233 54.73 72.77 REMARK 500 SER A 234 116.57 162.56 REMARK 500 ASN A 235 52.09 -113.56 REMARK 500 ASN A 236 74.23 -161.60 REMARK 500 PRO A 238 158.55 -45.26 REMARK 500 ALA A 250 -72.82 -37.77 REMARK 500 ALA A 256 25.51 34.41 REMARK 500 VAL A 259 30.98 -144.36 REMARK 500 ALA A 260 -37.15 -165.37 REMARK 500 GLN A 264 11.21 -147.53 REMARK 500 ASN A 265 14.71 -169.71 REMARK 500 GLU A 267 139.36 -39.04 REMARK 500 CYS A 276 -17.11 -39.60 REMARK 500 CYS A 278 21.68 -75.81 REMARK 500 VAL A 281 -34.17 -147.85 REMARK 500 PRO A 295 124.56 -33.80 REMARK 500 LEU A 300 132.32 -22.77 REMARK 500 LYS A 327 -4.90 -54.96 REMARK 500 SER A 346 -18.49 178.10 REMARK 500 CYS A 352 -9.21 -44.16 REMARK 500 VAL A 394 11.05 -59.50 REMARK 500 SER A 414 32.58 -99.49 REMARK 500 ASN A 415 -32.36 -139.29 REMARK 500 PRO A 417 -0.84 -58.55 REMARK 500 ASP A 419 60.01 -115.41 REMARK 500 GLN A 442 -70.07 -65.04 REMARK 500 SER A 452 40.80 30.99 REMARK 500 ALA A 454 79.22 -108.61 REMARK 500 ALA A 455 -166.00 -110.48 REMARK 500 PRO A 458 45.67 -79.93 REMARK 500 GLU A 462 -16.34 -170.85 REMARK 500 ILE A 463 -33.22 -136.31 REMARK 500 ARG A 465 -93.80 -70.14 REMARK 500 ASP A 466 79.35 -57.29 REMARK 500 MET A 467 -36.03 -157.82 REMARK 500 LEU B 229 -74.23 -65.34 REMARK 500 LYS B 232 65.70 19.36 REMARK 500 ALA B 233 53.99 -102.86 REMARK 500 SER B 234 133.66 166.27 REMARK 500 ASN B 236 67.22 72.96 REMARK 500 MET B 244 -14.74 -45.66 REMARK 500 ALA B 250 -86.53 -60.19 REMARK 500 ALA B 260 51.02 -177.77 REMARK 500 ASN B 261 -67.12 -122.35 REMARK 500 REMARK 500 THIS ENTRY HAS 162 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LYS D 349 -10.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN A 236 46.0 L L OUTSIDE RANGE REMARK 500 GLU B 267 45.9 L L OUTSIDE RANGE REMARK 500 PRO C 458 45.3 L L OUTSIDE RANGE REMARK 500 ASN D 236 46.6 L L OUTSIDE RANGE REMARK 500 PHE D 351 24.4 L L OUTSIDE RANGE REMARK 500 GLU D 462 24.3 L L OUTSIDE RANGE REMARK 500 LYS G 696 22.9 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 830 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH A 834 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH B 845 DISTANCE = 5.29 ANGSTROMS REMARK 525 HOH B 879 DISTANCE = 5.80 ANGSTROMS REMARK 525 HOH B 884 DISTANCE = 6.67 ANGSTROMS REMARK 525 HOH C 826 DISTANCE = 5.47 ANGSTROMS REMARK 525 HOH D 793 DISTANCE = 5.71 ANGSTROMS REMARK 525 HOH D 820 DISTANCE = 6.04 ANGSTROMS REMARK 525 HOH D 845 DISTANCE = 5.78 ANGSTROMS REMARK 525 HOH D 848 DISTANCE = 5.33 ANGSTROMS REMARK 525 HOH D 854 DISTANCE = 6.91 ANGSTROMS

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 A 775 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 B 776 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 C 777 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 471 D 778

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1K7L RELATED DB: PDB REMARK 900 THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN REMARK 900 PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A REMARK 900 CO-ACTIVATOR PEPTIDE REMARK 900 RELATED ID: 1K74 RELATED DB: PDB REMARK 900 THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE REMARK 900 HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND REMARK 900 BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS REMARK 900 RETINOIC ACID AND CO-ACTIVATOR PEPTIDES

DBREF 1KKQ A 200 468 UNP Q07869 PPAR_HUMAN 200 468 DBREF 1KKQ B 200 468 UNP Q07869 PPAR_HUMAN 200 468 DBREF 1KKQ C 200 468 UNP Q07869 PPAR_HUMAN 200 468 DBREF 1KKQ D 200 468 UNP Q07869 PPAR_HUMAN 200 468 DBREF 1KKQ E 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357 DBREF 1KKQ G 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357 DBREF 1KKQ H 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357 DBREF 1KKQ F 682 700 UNP Q9Y618 NCOR2_HUMAN 2339 2357

SEQRES 1 A 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU SEQRES 2 A 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA SEQRES 3 A 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO SEQRES 4 A 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU SEQRES 5 A 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN SEQRES 6 A 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN SEQRES 7 A 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE SEQRES 8 A 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN SEQRES 9 A 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA SEQRES 10 A 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY SEQRES 11 A 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU SEQRES 12 A 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET SEQRES 13 A 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU SEQRES 14 A 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA SEQRES 15 A 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 16 A 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL SEQRES 17 A 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE SEQRES 18 A 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU SEQRES 19 A 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE SEQRES 20 A 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU SEQRES 21 A 269 LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 B 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU SEQRES 2 B 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA SEQRES 3 B 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO SEQRES 4 B 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU SEQRES 5 B 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN SEQRES 6 B 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN SEQRES 7 B 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE SEQRES 8 B 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN SEQRES 9 B 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA SEQRES 10 B 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY SEQRES 11 B 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU SEQRES 12 B 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET SEQRES 13 B 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU SEQRES 14 B 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA SEQRES 15 B 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 16 B 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL SEQRES 17 B 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE SEQRES 18 B 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU SEQRES 19 B 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE SEQRES 20 B 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU SEQRES 21 B 269 LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 C 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU SEQRES 2 C 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA SEQRES 3 C 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO SEQRES 4 C 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU SEQRES 5 C 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN SEQRES 6 C 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN SEQRES 7 C 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE SEQRES 8 C 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN SEQRES 9 C 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA SEQRES 10 C 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY SEQRES 11 C 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU SEQRES 12 C 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET SEQRES 13 C 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU SEQRES 14 C 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA SEQRES 15 C 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 16 C 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL SEQRES 17 C 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE SEQRES 18 C 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU SEQRES 19 C 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE SEQRES 20 C 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU SEQRES 21 C 269 LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 D 269 THR ALA ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU SEQRES 2 D 269 ALA TYR LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA SEQRES 3 D 269 ARG VAL ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO SEQRES 4 D 269 PHE VAL ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU SEQRES 5 D 269 LYS THR LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN SEQRES 6 D 269 ASN LYS GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN SEQRES 7 D 269 CYS THR SER VAL GLU THR VAL THR GLU LEU THR GLU PHE SEQRES 8 D 269 ALA LYS ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN SEQRES 9 D 269 ASP GLN VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA SEQRES 10 D 269 ILE PHE ALA MET LEU SER SER VAL MET ASN LYS ASP GLY SEQRES 11 D 269 MET LEU VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU SEQRES 12 D 269 PHE LEU LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET SEQRES 13 D 269 GLU PRO LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU SEQRES 14 D 269 GLU LEU ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA SEQRES 15 D 269 ILE ILE CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL SEQRES 16 D 269 GLY HIS ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL SEQRES 17 D 269 LEU ARG LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE SEQRES 18 D 269 PHE LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU SEQRES 19 D 269 ARG GLN LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE SEQRES 20 D 269 ILE LYS LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU SEQRES 21 D 269 LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 E 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET SEQRES 2 E 19 GLY LYS TYR ASP GLN TRP SEQRES 1 F 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET SEQRES 2 F 19 GLY LYS TYR ASP GLN TRP SEQRES 1 G 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET SEQRES 2 G 19 GLY LYS TYR ASP GLN TRP SEQRES 1 H 19 ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU MET SEQRES 2 H 19 GLY LYS TYR ASP GLN TRP

HET 471 A 775 45 HET 471 B 776 45 HET 471 C 777 45 HET 471 D 778 45

HETNAM 471 N-((2S)-2-({(1Z)-1-METHYL-3-OXO-3-[4-(TRIFLUOROMETHYL) HETNAM 2 471 PHENYL]PROP-1-ENYL}AMINO)-3-{4-[2-(5-METHYL-2-PHENYL- HETNAM 3 471 1,3-OXAZOL-4-YL)ETHOXY]PHENYL}PROPYL)PROPANAMIDE

FORMUL 9 471 4(C35 H36 F3 N3 O4) FORMUL 13 HOH *330(H2 O)

HELIX 1 1 LYS A 204 LEU A 215 1 12 HELIX 2 2 ASN A 221 SER A 230 1 10 HELIX 3 3 ASP A 243 VAL A 255 1 13 HELIX 4 4 ARG A 271 CYS A 276 1 6 HELIX 5 5 VAL A 281 LYS A 292 1 12 HELIX 6 6 ASP A 301 TYR A 311 1 11 HELIX 7 7 GLY A 312 SER A 322 1 11 HELIX 8 8 ALA A 333 GLY A 335 5 3 HELIX 9 9 ARG A 341 LYS A 345 1 5 HELIX 10 10 PRO A 350 ASP A 353 5 4 HELIX 11 11 ILE A 354 ASN A 366 1 13 HELIX 12 12 ASP A 371 CYS A 384 1 14 HELIX 13 13 GLY A 395 LEU A 412 1 18 HELIX 14 14 PHE A 421 LEU A 433 1 13 HELIX 15 15 LEU A 433 GLN A 445 1 13 HELIX 16 16 SER B 205 PHE B 218 1 14 HELIX 17 17 ASN B 221 SER B 230 1 10 HELIX 18 18 THR B 246 VAL B 255 1 10 HELIX 19 19 ALA B 268 CYS B 275 1 8 HELIX 20 20 SER B 280 LYS B 292 1 13 HELIX 21 21 ASP B 301 SER B 322 1 22 HELIX 22 22 ARG B 341 LYS B 345 1 5 HELIX 23 23 MET B 355 ASN B 366 1 12 HELIX 24 24 ALA B 367 GLU B 369 5 3 HELIX 25 25 ASP B 371 CYS B 384 1 14 HELIX 26 26 ASN B 393 HIS B 416 1 24 HELIX 27 27 PHE B 421 ILE B 446 1 26 HELIX 28 28 LYS C 204 ALA C 213 1 10 HELIX 29 29 ALA C 213 PHE C 218 1 6 HELIX 30 30 ASN C 221 SER C 230 1 10 HELIX 31 31 ASP C 243 VAL C 255 1 13 HELIX 32 32 GLU C 267 ILE C 272 1 6 HELIX 33 33 GLU C 282 ILE C 294 1 13 HELIX 34 34 ASP C 301 GLY C 312 1 12 HELIX 35 35 TYR C 314 LEU C 321 1 8 HELIX 36 36 SER C 322 MET C 325 5 4 HELIX 37 37 ALA C 333 GLY C 335 5 3 HELIX 38 38 ARG C 341 SER C 346 1 6 HELIX 39 39 PRO C 350 ILE C 354 5 5 HELIX 40 40 MET C 355 ASN C 366 1 12 HELIX 41 41 ALA C 367 GLU C 369 5 3 HELIX 42 42 ASP C 371 CYS C 384 1 14 HELIX 43 43 GLY C 395 HIS C 416 1 22 HELIX 44 44 LEU C 422 GLN C 442 1 21 HELIX 45 45 LEU D 203 PHE D 218 1 16 HELIX 46 46 ASN D 221 LEU D 229 1 9 HELIX 47 47 ASP D 243 THR D 253 1 11 HELIX 48 48 LYS D 257 GLY D 262 1 6 HELIX 49 49 HIS D 274 ILE D 294 1 21 HELIX 50 50 GLY D 296 LEU D 300 5 5 HELIX 51 51 ASP D 301 SER D 322 1 22 HELIX 52 52 ALA D 333 GLY D 335 5 3 HELIX 53 53 ARG D 341 LYS D 345 1 5 HELIX 54 54 PHE D 351 ASN D 366 1 16 HELIX 55 55 ALA D 367 GLU D 369 5 3 HELIX 56 56 ASP D 371 ILE D 382 1 12 HELIX 57 57 GLY D 395 GLN D 413 1 19 HELIX 58 58 PHE D 421 GLN D 445 1 25 HELIX 59 59 LEU E 685 ALA E 692 1 8 HELIX 60 60 LEU F 685 LEU F 693 1 9 HELIX 61 61 LEU G 685 LYS G 691 1 7 HELIX 62 62 LEU H 685 LYS H 691 1 7

SHEET 1 A 3 PHE A 239 ILE A 241 0 SHEET 2 A 3 GLY A 337 THR A 340 1 O PHE A 338 N PHE A 239 SHEET 3 A 3 GLY A 329 VAL A 332 -1 N VAL A 332 O GLY A 337 SHEET 1 B 4 PHE B 239 ILE B 241 0 SHEET 2 B 4 GLY B 337 THR B 340 1 O THR B 340 N ILE B 241 SHEET 3 B 4 GLY B 329 VAL B 332 -1 N VAL B 332 O GLY B 337 SHEET 4 B 4 MET B 325 ASN B 326 -1 N ASN B 326 O GLY B 329 SHEET 1 C 3 PHE C 239 ILE C 241 0 SHEET 2 C 3 GLY C 337 THR C 340 1 O PHE C 338 N PHE C 239 SHEET 3 C 3 GLY C 329 VAL C 332 -1 N VAL C 332 O GLY C 337 SHEET 1 D 4 PHE D 239 ILE D 241 0 SHEET 2 D 4 GLY D 337 THR D 340 1 O PHE D 338 N ILE D 241 SHEET 3 D 4 GLY D 329 VAL D 332 -1 N MET D 330 O ILE D 339 SHEET 4 D 4 MET D 325 ASN D 326 -1 N ASN D 326 O GLY D 329

CISPEP 1 LYS A 349 PRO A 350 0 0.05 CISPEP 2 LYS B 349 PRO B 350 0 0.38 CISPEP 3 LYS C 349 PRO C 350 0 -0.34 CISPEP 4 LYS D 349 PRO D 350 0 0.28

SITE 1 AC1 15 LEU A 254 GLU A 269 ILE A 272 PHE A 273 SITE 2 AC1 15 CYS A 275 CYS A 276 SER A 280 TYR A 314 SITE 3 AC1 15 VAL A 332 PHE A 351 ILE A 354 HIS A 440 SITE 4 AC1 15 VAL A 444 LEU A 456 HOH A 798 SITE 1 AC2 14 LEU B 254 ILE B 272 CYS B 276 THR B 279 SITE 2 AC2 14 SER B 280 TYR B 314 MET B 330 VAL B 332 SITE 3 AC2 14 LEU B 344 PHE B 351 ILE B 354 MET B 355 SITE 4 AC2 14 HIS B 440 HOH B 794 SITE 1 AC3 15 ILE C 241 ILE C 272 PHE C 273 CYS C 275 SITE 2 AC3 15 CYS C 276 GLN C 277 THR C 279 SER C 280 SITE 3 AC3 15 TYR C 314 MET C 330 VAL C 332 PHE C 351 SITE 4 AC3 15 ILE C 354 HIS C 440 HOH C 816 SITE 1 AC4 13 LEU D 254 GLU D 269 ILE D 272 PHE D 273 SITE 2 AC4 13 CYS D 276 GLN D 277 SER D 280 TYR D 314 SITE 3 AC4 13 MET D 330 VAL D 332 LEU D 344 PHE D 351 SITE 4 AC4 13 HOH D 779

CRYST1 103.409 112.773 123.954 90.00 90.00 90.00 P 21 21 21 16

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.009670 0.000000 0.000000 0.00000

SCALE2 0.000000 0.008867 0.000000 0.00000

SCALE3 0.000000 0.000000 0.008068 0.00000